SBH
EMN icon

Segall Bryant & Hamill’s Eastman Chemical EMN Stock Holding History

Segall Bryant & Hamill’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-55,546
Closed -$4.26M – 363
2023
Q3 		$4.26M Sell
55,546
-8,140
-13% -$675K 0.05% 345
2023
Q2 		$5.33M Sell
63,686
-5,255
-8% -$427K 0.06% 328
2023
Q1 		$5.81M Sell
68,941
-734
-1% -$63K 0.06% 316
2022
Q4 		$5.67M Sell
69,675
-70,531
-50% -$5.68M 0.06% 304
2022
Q3 		$9.98M Sell
140,206
-217,241
-61% -$19.5M 0.12% 206
2022
Q2 		$32M Buy
357,447
+719
+0.2% +$74.4K 0.36% 78
2022
Q1 		$40M Buy
356,728
+141,257
+66% +$16.6M 0.38% 76
2021
Q4 		$26M Buy
215,471
+182,415
+552% +$20.3M 0.24% 113
2021
Q3 		$3.33M Buy
33,056
+2,230
+7% +$246K 0.03% 400
2021
Q2 		$3.6M Buy
30,826
+1,167
+4% +$140K 0.03% 385
2021
Q1 		$3.27M Sell
29,659
-90
-0.3% -$9.77K 0.03% 409
2020
Q4 		$2.98M Hold
29,749
– – 0.03% 368
2020
Q3 		$2.32M Sell
29,749
-6,955
-19% -$524K 0.03% 375
2020
Q2 		$2.56M Sell
36,704
-3,483
-9% -$219K 0.04% 301
2020
Q1 		$1.87M Sell
40,187
-8,602
-18% -$552K 0.04% 343
2019
Q4 		$3.88M Sell
48,789
-1,800
-4% -$138K 0.06% 289
2019
Q3 		$3.74M Sell
50,589
-1,400
-3% -$100K 0.06% 314
2019
Q2 		$4.05M Buy
51,989
+1,110
+2% +$84.3K 0.06% 307
2019
Q1 		$3.87M Sell
50,879
-14,141
-22% -$1.12M 0.06% 312
2018
Q4 		$4.75M Sell
65,020
-6,324
-9% -$504K 0.08% 265
2018
Q3 		$6.83M Sell
71,344
-2,085
-3% -$207K 0.1% 248
2018
Q2 		$7.34M Buy
73,429
+19,516
+36% +$2.06M 0.11% 234
2018
Q1 		$5.69M Sell
53,913
-1,750
-3% -$177K 0.13% 175
2017
Q4 		$5.16M Sell
55,663
-861
-2% -$78.2K 0.11% 196
2017
Q3 		$5.12M Sell
56,524
-1,100
-2% -$93.6K 0.12% 187
2017
Q2 		$4.84M Sell
57,624
-1,392
-2% -$112K 0.11% 194
2017
Q1 		$4.77M Sell
59,016
-1,050
-2% -$82.6K 0.12% 183
2016
Q4 		$4.52M Sell
60,066
-1,500
-2% -$108K 0.11% 189
2016
Q3 		$4.17M Sell
61,566
-3,029
-5% -$203K 0.11% 201
2016
Q2 		$4.39M Sell
64,595
-1,500
-2% -$110K 0.12% 191
2016
Q1 		$4.77M Sell
66,095
-701
-1% -$45.9K 0.12% 194
2015
Q4 		$4.51M Sell
66,796
-125
-0.2% -$8.75K 0.11% 214
2015
Q3 		$4.33M Sell
66,921
-640
-0.9% -$47.2K 0.11% 223
2015
Q2 		$5.53M Sell
67,561
-2,321
-3% -$179K 0.12% 208
2015
Q1 		$4.84M Sell
69,882
-138,386
-66% -$9.99M 0.11% 220
2014
Q4 		$15.8M Sell
208,268
-112,975
-35% -$8.93M 0.36% 91
2014
Q3 		$26M Buy
321,243
+111,565
+53% +$9.31M 0.6% 46
2014
Q2 		$18.3M Sell
209,678
-8,474
-4% -$736K 0.44% 73
2014
Q1 		$18.8M Sell
218,152
-279,687
-56% -$22.9M 0.45% 69
2013
Q4 		$40.2M Sell
497,839
-30,731
-6% -$2.39M 0.93% 22
2013
Q3 		$41.2M Sell
528,570
-6,031
-1% -$464K 1.02% 18
2013
Q2 		$37.4M Buy
+534,601
New +$37.3M 0.99% 20

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Segall Bryant & Hamill's EMN Position: Q4 2023 in Review

Segall Bryant & Hamill sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 55,546 shares — an estimated $4.26M sold.

Segall Bryant & Hamill first reported a position in EMN in Q2 2013 and held it in 42 quarters. The position peaked at $41.2M in Q3 2013. 711 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

  • Segall Bryant & Hamill reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 55,546 Eastman Chemical shares in Q4 2023, an estimated $4.26M.
  • Segall Bryant & Hamill first reported a position in Eastman Chemical in Q2 2013 and held it in 42 quarters.
  • Segall Bryant & Hamill's Eastman Chemical position peaked at $41.2M in Q3 2013.
  • 711 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Segall Bryant & Hamill's 13F filing for Q4 2023, filed 14 Feb 2024.